Research
KPV research has reached cells and animals, but not people
Research does not mean one thing.
A dish of cells, an animal and a person answer different questions.
For KPV, the record has the first two and not the third.
Checked against FDA records and published studies on September 28, 2026.
- Cell work
- Early lab clues
- Animal work
- Early signals
- Human work
- None found
PART A
Read from the lab toward real care
Each step adds facts. One step cannot replace the next.
Cells in a dish
In human gut and immune cells grown in a lab, KPV reduced signs tied to inflammation.
The FDA said it is still not known exactly what KPV acts on inside the body.
Studies in animals
Mouse bowel studies found less inflammation and an earlier return of lost weight after KPV exposure.
Other animal work looked at scraped rabbit eyes, mouse belly inflammation and bowel tumors caused in a lab.
Studies in people
The FDA found no study, case report or record of anyone taking KPV, whether swallowed, rubbed on the skin, sprayed in the nose or injected.
Searches on September 28, 2026 of ClinicalTrials.gov, the government list of medical studies, and PubMed, the government index of medical journal articles, also found no KPV study or case report in people.
PART B
Each result, and what it cannot tell us
Press “What was found” to see each result, or “What it cannot tell us” to see its limit. Keep both in mind.
What was found
Bowel research
KPV showed signs of less inflammation in mouse and cell tests.
Skin delivery
Researchers used tiny skin holes or a weak current to move KPV through donated skin in a lab.
Regulatory review
FDA reviewed proposed KPV uses for wounds and inflammatory conditions.
What it cannot tell us
Bowel research
A mouse or cell result does not prove a benefit for a person with bowel disease.
Skin delivery
KPV did not cross intact donated skin in an amount the lab could measure without help.
Regulatory review
FDA said the record could not show whether KPV works in people for the proposed uses.
PART C
What would change the answer
The missing work is a fair test in people, not a stronger sales claim.
A human study needs a clearly named product, a health question, measured results and a full report of problems.
Until that work exists, a firm claim about benefit or human safety goes past the reviewed record.
SOURCES
Chapter endnotes
These are the journal articles and the FDA review behind each step above.